Literature DB >> 32320931

Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: Association with quality of life and stigma.

Mario Tombini1, Giovanni Assenza2, Livia Quintiliani3, Lorenzo Ricci2, Jacopo Lanzone2, Martina Ulivi2, Vincenzo Di Lazzaro2.   

Abstract

OBJECTIVE: The objective of the study was to assess depressive symptoms (DS) and difficulties in emotion regulation (ER) in adult people with epilepsy (PWE) and their correlation with quality of life and stigmatization feelings of patients.
MATERIALS AND METHODS: We enrolled consecutively 110 PWE who completed the Beck Depression Inventory-II (BDI-II) questionnaire and, for the first time, the Italian translation of Difficulties in Emotion Regulation Scale (DERS) to evaluate DS and ER. They also fulfilled the Italian version of the Stigma Scale of Epilepsy (SSE), which allowed the quantification of the stigma perception by our cohort of patients and a 3-item Jacoby's Stigma Scale (JSS) and QOLIE-31 (Q31) for the evaluation of stigma and the quality of life. The results of BDI-II and DERS were correlated with clinical details of PWE, as well as the Q31 and SSE scores. Finally, a multiple stepwise regression analysis was applied to identify the main factors affecting DS and ER difficulties in these patients.
RESULTS: About 30% of PWE evidenced DS, of which 17.3% showed a BDI-II score higher than 19, suggestive of moderate to severe DS. Several factors related to epilepsy (seizure frequency, number of antiepileptic drugs (AEDs)) as well as ER and quality of life/stigmatization perception resulted significantly correlated with DS. As a new finding, the main factors affecting DS in PWE turned out to be the difficulties in ER and quality of life and stigma perception (as evaluated through Q31 and JSS scores).
CONCLUSIONS: Our findings evidenced that DS in PWE are highly prevalent and strongly correlated with ER difficulties that mostly influence DS together with quality of life and stigma perception. Depressive symptoms and emotion dysregulation are linked by a bidirectional relationship and are significantly associated with worse quality of life and higher stigmatization feelings.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depressive symptoms; Emotion regulation; Epilepsy; Quality of life; Stigma

Year:  2020        PMID: 32320931     DOI: 10.1016/j.yebeh.2020.107073

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  13 in total

1.  Antiseizure medications (antiepileptic drugs) in adults: starting, monitoring and stopping.

Authors:  Heather Angus-Leppan; Michael R Sperling; Vicente Villanueva
Journal:  J Neurol       Date:  2022-09-24       Impact factor: 6.682

2.  The Bilateral Precuneus as a Potential Neuroimaging Biomarker for Right Temporal Lobe Epilepsy: A Support Vector Machine Analysis.

Authors:  Chunyan Huang; Yang Zhou; Yi Zhong; Xi Wang; Yunhua Zhang
Journal:  Front Psychiatry       Date:  2022-06-15       Impact factor: 5.435

3.  Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening.

Authors:  Giovanni Assenza; Jacopo Lanzone; Francesco Brigo; Antonietta Coppola; Giancarlo Di Gennaro; Vincenzo Di Lazzaro; Lorenzo Ricci; Andrea Romigi; Mario Tombini; Oriano Mecarelli
Journal:  Front Neurol       Date:  2020-07-03       Impact factor: 4.003

4.  The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: Young people and caregiver survey.

Authors:  Colin Reilly; Amy Muggeridge; J Helen Cross
Journal:  Seizure       Date:  2021-01-08       Impact factor: 3.184

5.  The Impact of COVID-19 Lockdown on People With Epilepsy and Vagal Nerve Stimulation.

Authors:  Eleonora Grande; Tommaso Tufo; Marco Ciavarro; Ines Di Muccio; Filomena Fuggetta; Martina Silvestri; Giuseppina Bevacqua; Jacopo Lanzone; Giovanni Assenza
Journal:  Front Neurol       Date:  2021-02-26       Impact factor: 4.003

6.  SARS CoV2 infection in a young subject affected by arginosuccinate synthase deficiency: A case report of epilepsy worsening.

Authors:  N Vitturi; L Lenzini; F Francini-Pesenti; G Gugelmo; A Avogaro
Journal:  Mol Genet Metab Rep       Date:  2020-12-11

7.  Perceived quality of life (QOLIE-31-P), depression (NDDI-E), anxiety (GAD-7), and insomnia in patients with epilepsy attended at a refractory epilepsy unit in real-life clinical practice.

Authors:  Alicia Gonzalez-Martinez; Álvaro Planchuelo-Gómez; Alba Vieira Campos; Francisco Martínez-Dubarbie; José Vivancos; María De Toledo-Heras
Journal:  Neurol Sci       Date:  2021-09-15       Impact factor: 3.830

8.  Validation of the Chinese Version of the Stigma Scale of Epilepsy.

Authors:  Yuanxia Wu; Kailing Huang; Shirui Wen; Bo Xiao; Li Feng
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

9.  COVID-19, de novo seizures, and epilepsy: a systematic review.

Authors:  Ali A Asadi-Pooya; Leila Simani; Mina Shahisavandi; Zohreh Barzegar
Journal:  Neurol Sci       Date:  2020-11-25       Impact factor: 3.830

10.  Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center.

Authors:  Mariacarolina Vacca; Mariana Fernandes; Matteo Spanetta; Fabio Placidi; Francesca Izzi; Caterina Lombardo; Nicola Biagio Mercuri; Claudio Liguori
Journal:  Neurol Sci       Date:  2021-09-15       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.